Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems
Guardado en:
Autores principales: | , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro |
Aporte de: |
id |
todo:paper_02699370_v22_n15_p2046_Toibaro |
---|---|
record_format |
dspace |
spelling |
todo:paper_02699370_v22_n15_p2046_Toibaro2023-10-03T15:14:25Z Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems Toibaro, J.J. Losso, M.H. aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis |
spellingShingle |
aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis Toibaro, J.J. Losso, M.H. Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
topic_facet |
aminotransferase cytochrome P450 3A4 glycoprotein P lopinavir plus ritonavir proteinase inhibitor rifampicin ritonavir ritonavir plus saquinavir saquinavir unclassified drug aminotransferase blood level clinical trial drug absorption drug excretion drug metabolism highly active antiretroviral therapy human Human immunodeficiency virus infection letter liver toxicity mixed infection patient compliance pharmacokinetics priority journal side effect tuberculosis AIDS-Related Opportunistic Infections Antibiotics, Antitubercular Drug Interactions HIV Protease Inhibitors Humans Liver Diseases Research Design Rifampin Tuberculosis |
format |
JOUR |
author |
Toibaro, J.J. Losso, M.H. |
author_facet |
Toibaro, J.J. Losso, M.H. |
author_sort |
Toibaro, J.J. |
title |
Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
title_short |
Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
title_full |
Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
title_fullStr |
Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
title_full_unstemmed |
Pharmacokinetics interaction studies between rifampicin and protease inhibitors: Methodological problems |
title_sort |
pharmacokinetics interaction studies between rifampicin and protease inhibitors: methodological problems |
url |
http://hdl.handle.net/20.500.12110/paper_02699370_v22_n15_p2046_Toibaro |
work_keys_str_mv |
AT toibarojj pharmacokineticsinteractionstudiesbetweenrifampicinandproteaseinhibitorsmethodologicalproblems AT lossomh pharmacokineticsinteractionstudiesbetweenrifampicinandproteaseinhibitorsmethodologicalproblems |
_version_ |
1782027622774996992 |